- Home
- ERAS vs CARE Comparison
ERAS vs CARE Comparison
Compare ERAS & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- CARE
- Stock Information
- Founded
- ERAS 2018
- CARE 1974
- Country
- ERAS United States
- CARE United States
- Employees
- ERAS N/A
- CARE N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- CARE Major Banks
- Sector
- ERAS Health Care
- CARE Finance
- Exchange
- ERAS Nasdaq
- CARE Nasdaq
- Market Cap
- ERAS 348.4M
- CARE 330.3M
- IPO Year
- ERAS 2021
- CARE N/A
- Fundamental
- Price
- ERAS $1.37
- CARE $16.58
- Analyst Decision
- ERAS Strong Buy
- CARE Buy
- Analyst Count
- ERAS 6
- CARE 2
- Target Price
- ERAS $4.83
- CARE $21.50
- AVG Volume (30 Days)
- ERAS 1.7M
- CARE 103.0K
- Earning Date
- ERAS 08-11-2025
- CARE 07-24-2025
- Dividend Yield
- ERAS N/A
- CARE N/A
- EPS Growth
- ERAS N/A
- CARE 111.89
- EPS
- ERAS N/A
- CARE 1.20
- Revenue
- ERAS N/A
- CARE $146,558,000.00
- Revenue This Year
- ERAS N/A
- CARE $10.63
- Revenue Next Year
- ERAS N/A
- CARE $14.34
- P/E Ratio
- ERAS N/A
- CARE $13.87
- Revenue Growth
- ERAS N/A
- CARE 18.52
- 52 Week Low
- ERAS $1.01
- CARE $12.28
- 52 Week High
- ERAS $3.45
- CARE $20.40
- Technical
- Relative Strength Index (RSI)
- ERAS 46.81
- CARE 61.08
- Support Level
- ERAS $1.31
- CARE $16.14
- Resistance Level
- ERAS $1.59
- CARE $16.88
- Average True Range (ATR)
- ERAS 0.13
- CARE 0.32
- MACD
- ERAS -0.02
- CARE -0.02
- Stochastic Oscillator
- ERAS 25.00
- CARE 81.08
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.